Patent application number | Description | Published |
20080220550 | METHOD OF PRODUCING N-TYPE GROUP-13 NITRIDE SEMICONDUCTOR, METHOD OF FORMING CURRENT CONFINEMENT LAYER, METHOD OF PRODUCING SURFACE EMITTING LASER, METHOD OF CHANGING RESISTANCE OF NITRIDE SEMICONDUCTOR AND METHOD OF PRODUCING SEMICONDUCTOR LASER - The object of the present invention is to provide a method of producing an n-type group-13 nitride semiconductor which enables resistance of the n-type group-13 nitride semiconductor to be changed, as well as, a method of producing a laser using the above method to produce a current confinement structure. There is provided a method of producing an n-type group-13 nitride semiconductor, including: preparing an n-type group-13 nitride semiconductor; and irradiating the n-type group-13 nitride semiconductor with light having a wavelength of 350 nm or more to 370 nm or less so as not to change a crystal structure of the n-type group-13 nitride semiconductor before and after the light irradiation, thereby increasing resistance of the n-type group-13 nitride semiconductor. | 09-11-2008 |
20100196278 | PHOTOACOUSTIC IMAGING AGENT - A molecular probe marked with a color center material is used as a photoacoustic imaging agent to obtain an acoustic signal of practically adequate intensity using weak near-infrared light, which has good in vivo penetration depth but has small excitation energy, and is within the maximum permissible exposure, in photoacoustic tomography (PAT) diagnosis of a living body. | 08-05-2010 |
20100197937 | NOVEL COMPOUND, PROBE CONTAINING THE NOVEL COMPOUND, AND FLUORESCENCE-IMAGING CONTRAST AGENT CONTAINING THE NOVEL COMPOUND OR THE PROBE - A compound represented by Formula (1) below, | 08-05-2010 |
20110028713 | AZA COMPOUNDS AND PRODUCTION METHOD THEREOF, AND METAL COMPLEXES AS MRI CONTRAST AGENTS - A core of a cyclic structure represented by (āNā(CH | 02-03-2011 |
20120070375 | COMPLEX AND CONTRAST AGENT FOR PHOTOIMAGING USING THE SAME - There is provided a gelatin-ICG complex that can suppress leakage of ICG included therein. The complex has a gelatin derivative including at least one of a phospholipid covalently bonded to a gelatin or a cholesterol covalently bonded to a gelatin, and indocyanine green. | 03-22-2012 |
20130209367 | PARTICLE AND CONTRAST AGENT HAVING THE PARTICLE - There is provided an ICG-loaded polymer nanoparticle that is dynamically stable, prevents the leakage of contained ICG and the resulting discoloration, and has a high molar absorbance coefficient. The particle contains a hydrophilic dye having a sulfonate group and a hydrophobic polymer, and the particle further contains at least one of a lipid having a positively charged region, a nicotinic acid derivative and a thiamine derivative. | 08-15-2013 |
20130323178 | INDOCYANINE GREEN-CONTAINING PARTICLE AND CONTRAST AGENT FOR PHOTOACOUSTIC IMAGING HAVING THE PARTICLE - Provided is the following indocyanine green (ICG)-containing particle to be used as, for example, a contrast agent for fluorescent imaging or photoacoustic imaging. The leakage of ICG from the particle in a serum is prevented and hence the particle can stably retain ICG. According to a particle characterized by having an aggregate of indocyanine green and a phospholipid, the leakage of ICG from the particle in a serum or the like is prevented and hence ICG can be stably retained in the particle. | 12-05-2013 |
20130344001 | INDOCYANINE GREEN-CONTAINING PARTICLES, PHOTOACOUSTIC-IMAGING CONTRAST AGENT INCLUDING THE SAME, AND METHOD FOR PRODUCING THE INDOCYANINE GREEN-CONTAINING PARTICLES - Indocyanine green-containing particles each include a metal oxide particle or a metal particle and an aggregate of indocyanine green. The aggregate of indocyanine green has a relative maximum absorbance at 880 nm or more and 910 nm or less. | 12-26-2013 |
20140275521 | Aza metal complexes - A core of a cyclic structure represented by (āNā(CH | 09-18-2014 |
20140341813 | INDOCYANINE GREEN-CONTAINING PARTICLE AND METHOD OF PRODUCING THE PARTICLE - To encapsulate indocyanine green (ICG) at a high concentration in a liposome without causing the agglomeration of ICG so that ICG remains as a monomer in an ICG-containing particle to be used as, for example, a contrast agent for fluorescence imaging or photoacoustic imaging, provided is a method of producing an indocyanine green-containing particle, including the step of mixing indocyanine green, a particle, and a solution containing 1 mM or more and 10 M or less of a chaotropic agent. | 11-20-2014 |